Q2 STOCKS TO BUY

Eleventh-Hour Call Buyers Target Amgen (AMGN)

Amgen, Inc. (AMGN) calls continue to be popular

Digital Content Group
Mar 20, 2015 at 11:40 AM
facebook X logo linkedin


Amgen, Inc.'s (NASDAQ:AMGN) attempt to block a biosimilar of its Neuopogen infection-prevention drug -- which is manufactured by Novartis AG (ADR) (NYSE:NVS) -- was rejected by a U.S. judge. AMGN shares, however, appear unfazed, up 0.8% at $170.51 -- and traders are flocking to the stock's options pits to wager on additional upside.

Diving right in, AMGN's intraday call volume quadruples the typical amount, and more than doubles the number of puts on the tape. Seeing the most attention is the March 165 call, where it seems traders are buying new positions, in hopes the stock will extend its lead north of $165 through tonight's close, when the front-month options expire. Based on the call's volume-weighted average price (VWAP) of $7, breakeven on the trade is $172 (strike plus VWAP).

Shifting our attention, AMGN is a long-term technical outperformer. On a year-over-year basis, the shares have jumped nearly 39% -- and are now within striking distance of their record peak of $173.14, touched in early December.

Taking a step back, today's preference for long calls echoes the withstanding trend witnessed in AMGN's options pits. Specifically, the equity's 10-day call/put volume ratio across the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) is 2.12, with long calls more than doubling puts. What's more, the ratio is higher than 87% of comparable readings from the previous 52 weeks.

In other news, a joint venture between Amgen, Inc. (NASDAQ:AMGN) and Astellas Pharma Inc. has submitted an application to Japan's Ministry of Health, Labour and Welfare, seeking marketing approval for the cholesterol-fighting drug Repatha. The treatment is still awaiting approval in the U.S. and Europe.

 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter